La Paz Obtains Patent Rights for Atopy Testing Method Using Microneedle Patch
[Asia Economy Reporter Minji Lee] Lapas announced on the 8th that it has obtained a patent for a minimally invasive atopic dermatitis testing method and test kit using microneedle patches.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- "All Major Corporations Could Leave"... Business Community Fears Overseas Factory Relocation Due to Strike Risks
- The Victory of "Carving Up the Seats": Analysis of 504 Unopposed Winners
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
The company explained, "This is a minimally invasive microneedle method that can replace invasive biopsy methods, allowing for easy evaluation of the patient's skin condition."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
